Skip to content
Smart Scholars🛡 Scholar Shield🏛 Research Integrity Desk🧩 Portfolio Console📰 Journals🔧 DOI MembersTools🔎 Journal AuditGI GetIndexedDr DOI Doctor

Cite this DOI

10.46243/jst.2020.v5.i5.pp171-187 · Development and Charecterization of Caffeine and Quercetin Loaded Nasal Niosomal In-Situ Gel for Treatment of Depression

APA (7th edition)

P.Shilpa Chaudhari, & U. Sneha Gaikwad (2020). Development and Charecterization of Caffeine and Quercetin Loaded Nasal Niosomal In-Situ Gel for Treatment of Depression. *Journal of Science & Technology*, 171–187. https://doi.org/10.46243/jst.2020.v5.i5.pp171-187

⬇ text Italics are shown as *asterisks* in plain text — the journal or book title and the volume.

BibTeX

@article{pshilpachaudhari2020development,
  author    = {P.Shilpa Chaudhari and U. Sneha Gaikwad},
  title     = {{Development and Charecterization of Caffeine and Quercetin Loaded Nasal Niosomal In-Situ Gel for Treatment of Depression}},
  journal   = {Journal of Science \& Technology},
  year      = {2020},
  month     = {oct},
  number    = {Volume 5},
  pages     = {171--187},
  publisher = {Longman Publishers},
  issn      = {2456-5660},
  doi       = {10.46243/jst.2020.v5.i5.pp171-187},
  url       = {https://doi.org/10.46243/jst.2020.v5.i5.pp171-187},
  language  = {en},
  abstract  = {Caffeine and Quercetin both are used in combination for the treatment of patient with depression as they are adenosine antagonist due to which they elevate the level of neurotransmitters. The study was designed with two aims. First, is to enhance the solubility and bioavailability of BCS Class II i.e. Quercetin; secondly to ease administration of the formulation to the patient with depression. The culmination of this study, the caffeine and quercetin loaded niosomal in-situ gel for nose-to-brain delivery was formulated. Niosomes were prepared and optimized by using definitive screening design whereas, the Niosomal in-situ gel were prepared and optimized using central composite design. The vesicle size of the optimized batch was found to be 0.281±0.26µm. The \% EE of all niosomal batches was found to be in a range of 81.52±0.21\% to 98.72±0.16\% for Caffeine and 94.3±0.31 to 99.73±0.23 for Quercetin and the cumulative \% release was found to be in a range of 72.09±0.18\% to 103.3±0.26\% for Caffeine and 10.9±0.31\% to 37.06±0.15\% for Quercetin at 4hrs. DSC, FTIR studies were performed for pure drug and optimized niosomal batch. All the gels as per design were formulated, where the Spreadability was found to be in range of 5.1±0.26cm to 7.9±0.16cm and viscosity after gelation in range of 1800±0.11cps to 4780±0.26cps. The \% drug permeated was found to be in range of 85.86±0.015\% to 98.61±0.024\% for Caffeine and 22.65±0.19\% to 33.23±0.34\% for Quercetin at 6hrs. These results indicated that niosomal In-situ gel can be used to enhance the bioavailability of drug by directly delivering the drug to the brain by avoiding first pass effect}
}

⬇ .bib

RIS (EndNote, Zotero, Mendeley)

TY  - JOUR
TI  - Development and Charecterization of Caffeine and Quercetin Loaded Nasal Niosomal In-Situ Gel for Treatment of Depression
AU  - P.Shilpa Chaudhari
AU  - U. Sneha Gaikwad
JO  - Journal of Science & Technology
PY  - 2020
DA  - 2020/10/14/
IS  - Volume 5
SP  - 171
EP  - 187
PB  - Longman Publishers
SN  - 2456-5660
LA  - en
AB  - Caffeine and Quercetin both are used in combination for the treatment of patient with depression as they are adenosine antagonist due to which they elevate the level of neurotransmitters. The study was designed with two aims. First, is to enhance the solubility and bioavailability of BCS Class II i.e. Quercetin; secondly to ease administration of the formulation to the patient with depression. The culmination of this study, the caffeine and quercetin loaded niosomal in-situ gel for nose-to-brain delivery was formulated. Niosomes were prepared and optimized by using definitive screening design whereas, the Niosomal in-situ gel were prepared and optimized using central composite design. The vesicle size of the optimized batch was found to be 0.281±0.26µm. The % EE of all niosomal batches was found to be in a range of 81.52±0.21% to 98.72±0.16% for Caffeine and 94.3±0.31 to 99.73±0.23 for Quercetin and the cumulative % release was found to be in a range of 72.09±0.18% to 103.3±0.26% for Caffeine and 10.9±0.31% to 37.06±0.15% for Quercetin at 4hrs. DSC, FTIR studies were performed for pure drug and optimized niosomal batch. All the gels as per design were formulated, where the Spreadability was found to be in range of 5.1±0.26cm to 7.9±0.16cm and viscosity after gelation in range of 1800±0.11cps to 4780±0.26cps. The % drug permeated was found to be in range of 85.86±0.015% to 98.61±0.024% for Caffeine and 22.65±0.19% to 33.23±0.34% for Quercetin at 6hrs. These results indicated that niosomal In-situ gel can be used to enhance the bioavailability of drug by directly delivering the drug to the brain by avoiding first pass effect
DO  - 10.46243/jst.2020.v5.i5.pp171-187
UR  - https://doi.org/10.46243/jst.2020.v5.i5.pp171-187
ER  -

⬇ .ris

CSL-JSON

{
    "type": "article-journal",
    "id": "10.46243/jst.2020.v5.i5.pp171-187",
    "DOI": "10.46243/jst.2020.v5.i5.pp171-187",
    "URL": "https://doi.org/10.46243/jst.2020.v5.i5.pp171-187",
    "title": "Development and Charecterization of Caffeine and Quercetin Loaded Nasal Niosomal In-Situ Gel for Treatment of Depression",
    "source": "Smart Scholars Registry",
    "container-title": "Journal of Science & Technology",
    "author": [
        {
            "family": "P.Shilpa Chaudhari"
        },
        {
            "family": "U. Sneha Gaikwad"
        }
    ],
    "issued": {
        "date-parts": [
            [
                2020,
                10,
                14
            ]
        ]
    },
    "issue": "Volume 5",
    "page": "171-187",
    "publisher": "Longman Publishers",
    "language": "en",
    "abstract": "Caffeine and Quercetin both are used in combination for the treatment of patient with depression as they are adenosine antagonist due to which they elevate the level of neurotransmitters. The study was designed with two aims. First, is to enhance the solubility and bioavailability of BCS Class II i.e. Quercetin; secondly to ease administration of the formulation to the patient with depression. The culmination of this study, the caffeine and quercetin loaded niosomal in-situ gel for nose-to-brain delivery was formulated. Niosomes were prepared and optimized by using definitive screening design whereas, the Niosomal in-situ gel were prepared and optimized using central composite design. The vesicle size of the optimized batch was found to be 0.281±0.26µm. The % EE of all niosomal batches was found to be in a range of 81.52±0.21% to 98.72±0.16% for Caffeine and 94.3±0.31 to 99.73±0.23 for Quercetin and the cumulative % release was found to be in a range of 72.09±0.18% to 103.3±0.26% for Caffeine and 10.9±0.31% to 37.06±0.15% for Quercetin at 4hrs. DSC, FTIR studies were performed for pure drug and optimized niosomal batch. All the gels as per design were formulated, where the Spreadability was found to be in range of 5.1±0.26cm to 7.9±0.16cm and viscosity after gelation in range of 1800±0.11cps to 4780±0.26cps. The % drug permeated was found to be in range of 85.86±0.015% to 98.61±0.024% for Caffeine and 22.65±0.19% to 33.23±0.34% for Quercetin at 6hrs. These results indicated that niosomal In-situ gel can be used to enhance the bioavailability of drug by directly delivering the drug to the brain by avoiding first pass effect",
    "ISSN": "2456-5660"
}

⬇ .json What citeproc and reference managers read; the DOI system hands it out for Accept: application/vnd.citationstyles.csl+json, and so does this registry's resolver.

From the record as registered (version 2) — the record and its history. Programs: https://registry.smartscholars.in/api.php?action=cite&doi=10.46243%2Fjst.2020.v5.i5.pp171-187 gives all four in one JSON answer.

Share this page

Share this page

Ask AI about this page

Everything Smart Scholars runs

Nine sites, one account. A journal starts at the audit; an author starts at Scholar Shield.

What we do: DOIs registered from what a journal already has · Crossref records completed — references, abstracts, licences, ORCID iDs, affiliations and ROR IDs, funding · DOIs that resolve · articles preserved · journals rated on the public record · see everything we do →

Book a free call

For journals & publishers

Start with the audit — ₹4,999 per journal, and the gate to everything else.

DOI care

Every service on one journal profile — each previews first and acts only on your approval.

  • DOI Doctor — check & repairevery DOI tested at doi.org and Crossref; dead links, abstracts, licences, ORCIDs
  • Smart Deposita new DOI from your PDF, Word file, article page, JATS XML or spreadsheet — every value shown with its source, deposited once you confirm it
  • DOI census (Excel)site against Crossref, both directions, with a copy-paste fix per article
  • Backfile DOIsDOIs for older articles that never had one — no per-DOI fee of ours
  • DOIs for conference proceedingsthe conference, the volume and every paper — registered in the organiser's own name
  • Scopus indexing guidethe minimum criteria, the 14 CSAB criteria and how a title is suggested — from Elsevier's own page
  • Embase indexing guidewhat Embase asks of a biomedical journal and how to suggest it
  • Write DOIs into OJSthe verified DOIs pushed onto your article pages through your own API
  • Silent-failure monitorweekly checks of site, OAI-PMH, Scholar tags, ISSN, preservation, hijack lists
  • Journal Radarevery journal, every day: SSL, DNS, redirects, robots.txt, OJS, DOIs, Crossref metadata, broken links — what broke since yesterday first
  • Verified metrics & badgesa public, dated, source-linked metrics page and a "cited by" badge
  • Quality dossier (PDF)one PDF for universities, authors and reviewers
  • Author citation enginethe citation steps emailed to each author from the journal's own mailbox
  • JATS XMLmachine-readable JATS per article
  • Duplicate articlesthe same paper published twice — you choose which copy stays

For authors & researchers

Free to use. Nothing you check is shared with the journal.

For institutions, sponsors & DOI operators

Smart Scholars

Mon–Sat, 10:00–19:00 IST. The Ask AI button on every page answers about our services at any hour.

News

Policies

What we can register a DOI for

20 kinds of record, one account, one place. Every one gets a DOI that resolves, metadata that indexes read, and a record that stays correct afterwards.

Journals

  • Journal articles
  • Journal titles
  • Pending publications
  • Peer reviews
  • Preprints & posted content

Books & conferences

  • Books
  • Book chapters
  • Book series
  • Book sets
  • Conference proceedings
  • Proceedings series
  • Conference papers

Other research output

  • Theses & dissertations
  • Reports & working papers
  • Report series
  • Standards
  • Databases
  • Datasets
  • Figures, tables & supplements

Funding

  • Grants & funding awards

Elsewhere

The same company, in the places our publishers already read.
Add Smart Scholars as a preferred source on GoogleSee more of our newsroom in Google’s Top Stories.
Smart Scholars · Every service on one pageNewsroom posts CC BY 4.0 · DOI metadata CC0 · everything else ©Data from OpenAlex (openalex.org), CC0 · Crossref · ISSN Portal · DOAJContact
WhatsApp